Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adverse events after first COVID-19 vaccination in patients with autoimmune diseases.
Boekel L, Kummer LY, van Dam KPJ, Hooijberg F, van Kempen Z, Vogelzang EH, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G. Boekel L, et al. Among authors: tas sw. Lancet Rheumatol. 2021 Aug;3(8):e542-e545. doi: 10.1016/S2665-9913(21)00181-8. Epub 2021 Jun 18. Lancet Rheumatol. 2021. PMID: 34179831 Free PMC article. No abstract available.
Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
Maracle CX, Agca R, Helder B, Meeuwsen JAL, Niessen HWM, Biessen EAL, de Winther MPJ, de Jager SCA, Nurmohamed MT, Tas SW. Maracle CX, et al. Among authors: tas sw. Atherosclerosis. 2018 Mar;270:33-41. doi: 10.1016/j.atherosclerosis.2018.01.032. Epub 2018 Jan 31. Atherosclerosis. 2018. PMID: 29407886 Free article.
Stakeholders' perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases.
Kosse LJ, Jessurun NT, Vonkeman HE, Tas SW, Nurmohamed MT, Hoentjen F, van Doorn MBA, van Puijenbroek EP, van den Bemt BJF, de Vries M. Kosse LJ, et al. Among authors: tas sw. Expert Opin Drug Saf. 2020 Nov;19(11):1521-1528. doi: 10.1080/14740338.2020.1803826. Epub 2020 Aug 12. Expert Opin Drug Saf. 2020. PMID: 32730115
Perspective of patients with autoimmune diseases on COVID-19 vaccination.
Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J, Nurmohamed MT, Boers M, Kuijpers TW, van Ham SM, Eftimov F, Wieske L, Rispens T, Wolbink GJ. Boekel L, et al. Among authors: tas sw. Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22. Lancet Rheumatol. 2021. PMID: 33655220 Free PMC article. No abstract available.
Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry".
van Vollenhoven RF, Tas SW, Nurmohamed MT. van Vollenhoven RF, et al. Among authors: tas sw. Ann Rheum Dis. 2023 Aug;82(8):e177. doi: 10.1136/annrheumdis-2021-221146. Epub 2021 Aug 13. Ann Rheum Dis. 2023. PMID: 34389606 Free PMC article. No abstract available.
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, van Dam KPJ, Stalman EW, Vogelzang EH, Cristianawati O, Keijzer S, Vidarsson G, Voskuyl AE, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G. Boekel L, et al. Among authors: tas sw. Lancet Rheumatol. 2021 Nov;3(11):e778-e788. doi: 10.1016/S2665-9913(21)00222-8. Epub 2021 Aug 6. Lancet Rheumatol. 2021. PMID: 34396154 Free PMC article.
Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate?
van Kempen ZLE, Wieske L, Stalman EW, Kummer LYL, van Dam PJ, Volkers AG, Boekel L, Toorop AA, Strijbis EMM, Tas SW, Wolbink GJ, Löwenberg M, van Sandt C, Ten Brinke A, Verstegen NJM, Steenhuis M, Kuijpers TW, van Ham SM, Rispens T, Eftimov F, Killestein J; T2B! immunity against SARS-CoV-2 study group. van Kempen ZLE, et al. Among authors: tas sw. Mult Scler Relat Disord. 2022 Jan;57:103416. doi: 10.1016/j.msard.2021.103416. Epub 2021 Nov 23. Mult Scler Relat Disord. 2022. PMID: 34847379 Free PMC article.
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.
Boekel L, Hooijberg F, Besten YR, Vogelzang EH, Steenhuis M, Leeuw M, Atiqi S, van Vollenhoven R, Lems WF, Bos WH, Wijbrandts CA, Gerritsen M, Krieckaert C, Voskuyl AE, van der Horst-Bruinsma IE, Tas SW, Boers M, Rispens T, Nurmohamed MT, Wolbink G. Boekel L, et al. Among authors: tas sw. Lancet Rheumatol. 2022 May;4(5):e310-e313. doi: 10.1016/S2665-9913(22)00009-1. Epub 2022 Feb 8. Lancet Rheumatol. 2022. PMID: 35156061 Free PMC article. No abstract available.
151 results